Cleared Traditional

K161341 - LIFESYS PACS

K161341 is an FDA 510(k) clearance for LIFESYS PACS, manufactured by Lifetrack Medical Systems, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 327-day FDA review.

K161341 · Lifetrack Medical Systems, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2017
Decision
327d
Days
Class 2
Risk

K161341 is an FDA 510(k) clearance for the LIFESYS PACS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Lifetrack Medical Systems, Inc. (Taguig City, PH). The FDA issued a Cleared decision on April 5, 2017 after a review of 327 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Lifetrack Medical Systems, Inc. devices

FDA 510(k) Submission Details - K161341

510(k) Number K161341 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 13, 2016
Decision Date April 05, 2017
Days to Decision 327 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
220d slower than avg
Panel avg: 107d · This submission: 327d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1236
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K161341.
syngo.CT View&GO
K170952 · Siemens Medical Solutions USA, Inc. · Apr 2017
Carestream Vue PACS
K170580 · Carestream Health, Inc. · Apr 2017
Synapse 3D Perfusion Analysis
K162287 · Fujifilm Medical Systems U.S.A, Inc. · Apr 2017
Move Forward 3D Motion Simulation Service
K162559 · Biomet, Inc. · Mar 2017
FDX Console (DR-ID300CL) Software
K170451 · Fujifilm Medical Systems U.S.A, Inc. · Mar 2017
Lung Nodule Assessment and Comparison Option (LNA)
K162484 · Philips Medical Systems Nederland B.V. · Feb 2017